Article

Improvement of liver disease and inflammation in patients with advanced HCV-related cirrhosis after antiviral therapy

2020-07-23

Abstract excerpt

<title>Abstract</title> <p>Eradication of hepatitis C virus (HCV) promotes an improvement in liver disease and deactivation of the immune system. Here, we aimed to evaluate the changes in liver disease scores and plasma biomarkers following HCV clearance with direct-acting antivirals (DAAs) in patients with advanced HCV-related cirrhosis. We performed a prospective study of patients with advanced cirrhosis (liver...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7b6ece89-5d8e-56fa-a11b-d79f19969350
DOI: 10.21203/rs.3.rs-45478/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Improvement of liver disease and inflammation in patients with advanced HCV-related cirrhosis after antiviral therapyDOI 10.21203/rs.3.rs-45478/v1Read

Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis.Semantic proximity Read

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection.Semantic proximity Read

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes.Semantic proximity Read

Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.Semantic proximity Read

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.Semantic proximity Read

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.Semantic proximity Read

Alterations in the hepatic microenvironment following direct-acting antiviral therapy for chronic hepatitis CSemantic proximity Read

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.Semantic proximity Read

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.Semantic proximity Read

100% sustained virological response and fibrosis improvement in real-life use of direct acting antivirals in genotype-1b recurrent hepatitis C following liver transplantation.Semantic proximity Read

Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.Semantic proximity Read